Harter Nicole, Mancini Anthony J
Division of Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 225 East Chicago Avenue, Box 107, Chicago, IL 60611-2605, USA.
Division of Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 225 East Chicago Avenue, Box 107, Chicago, IL 60611-2605, USA.
Pediatr Clin North Am. 2019 Apr;66(2):437-459. doi: 10.1016/j.pcl.2018.12.011.
Infantile hemangiomas (IH) are a common benign tumor of infancy, most being uncomplicated and not requiring therapy. Some IH may require treatment; the pediatric provider must be familiar with morphology, distribution, natural history, and associations of IH. Several treatment options are available for IH: current standard of care, oral propranolol. Other therapies include wound care; topical beta-blocker therapy for small, superficial, and uncomplicated IH; treatment of IH residua. In addition to functional compromise and other complications, potential for permanent deformity and eventual psychosocial stigmatization are important when considering the need for treatment of IH in a neonate or infant.
婴儿血管瘤(IH)是一种常见的婴儿期良性肿瘤,大多数情况不复杂,无需治疗。一些婴儿血管瘤可能需要治疗;儿科医生必须熟悉婴儿血管瘤的形态、分布、自然病史及相关情况。婴儿血管瘤有几种治疗选择:目前的护理标准是口服普萘洛尔。其他治疗方法包括伤口护理;针对小的、表浅的、不复杂的婴儿血管瘤的局部β受体阻滞剂治疗;婴儿血管瘤残留的治疗。除功能损害和其他并发症外,在考虑对新生儿或婴儿的婴儿血管瘤进行治疗时,永久性畸形的可能性以及最终的心理社会污名化也是重要因素。